Clinical Trials
31
Active:4
Completed:4
Trial Phases
4 Phases
Early Phase 1:3
Phase 1:3
Phase 2:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials
Not Applicable
15 (68.2%)Early Phase 1
3 (13.6%)Phase 1
3 (13.6%)Phase 2
1 (4.5%)Effect of Low Molecular Weight Heparin in Freeze-thaw Embryo Transfer Cycles in Women With Recurrent Implantation Failure
Completed
- Conditions
- Low Molecular Weight HeparinRecurrent Implantation FailureFETIVF
- Interventions
- Drug: Low Molecular Weight Heparine
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- The Second Hospital of Shandong University
- Target Recruit Count
- 392
- Registration Number
- NCT06991530
- Locations
- 🇨🇳
The Second Hospital of Shandong University, Jinan, Shandong, China
Effect of Salidroside on Pregnancy Outcomes in High Childbearing Age Patients in Viro Fertilization
Phase 2
Not yet recruiting
- Conditions
- SalidrosideRandomized Controlled TrialIn Vitro FertilizationAssisted Reproductive Technology
- Interventions
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- The Second Hospital of Shandong University
- Target Recruit Count
- 370
- Registration Number
- NCT06990685
- Locations
- 🇨🇳
The Second Hospital of Shandong University,, Jinan, Shandong, China
Epidemiological Study of Osteoporosis in the Elderly Population of Shandong Province
Recruiting
- Conditions
- OsteoporosisOsteoporosis (Senile)
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- The Second Hospital of Shandong University
- Target Recruit Count
- 2000
- Registration Number
- NCT06915935
- Locations
- 🇨🇳
Community/rural health service centres, Jinan, Shandong, China
Tubeless Surgery With Impaired Pulmonary Function
Not Applicable
Recruiting
- Conditions
- Lung Function DecreasedSurgery
- First Posted Date
- 2025-02-27
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- The Second Hospital of Shandong University
- Target Recruit Count
- 30
- Registration Number
- NCT06848751
- Locations
- 🇨🇳
The Second Hospital of Shandong University, Jinan, Shandong, China
Safety and Efficacy of CD19 CAR-T/CAR-NK Cells
Early Phase 1
Active, not recruiting
- Conditions
- Safety and Efficacy
- Interventions
- Biological: CAR-T/CAR-NK cells
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- The Second Hospital of Shandong University
- Target Recruit Count
- 10
- Registration Number
- NCT06596057
- Locations
- 🇨🇳
Shandong Province, Shandong, Shandong, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
No news found